These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2652343

  • 1. [Plasma cell leukemia. Study of 10 cases].
    López Guillermo A, Martí JM, Bladé J, Nomdedeu B, Montserrat E, Rozman C.
    Sangre (Barc); 1989 Feb; 34(1):28-31. PubMed ID: 2652343
    [Abstract] [Full Text] [Related]

  • 2. [Plasma cell leukemia. Study of 6 patients].
    Las Heras G, Ribera JM, Abella E, Batlle M, Flores A, Millá F, Feliu E.
    Sangre (Barc); 1992 Aug; 37(4):255-8. PubMed ID: 1514138
    [Abstract] [Full Text] [Related]

  • 3. [Plasma cell leukemia: our experience in 4 cases].
    Manso F, Bello JL, Feliu J, García de Bustos J, Losada G, Quevedo E.
    Rev Clin Esp; 1991 Nov; 189(7):328-30. PubMed ID: 1767090
    [Abstract] [Full Text] [Related]

  • 4. Significantly better prognosis for patients with primary plasma cell leukemia than for patients with secondary plasma cell leukemia.
    Cha CH, Park CJ, Huh JR, Chi HS, Suh CW, Kang YK.
    Acta Haematol; 2007 Nov; 118(3):178-82. PubMed ID: 17934254
    [Abstract] [Full Text] [Related]

  • 5. [Clinical and evolutive study of plasma cell leukemia. Apropos of 9 cases].
    Panizo Santos C, Cuesta Palomero B, Calasanz Abinzano MJ, Rifón Roca J, Rocha Hernando E.
    Rev Clin Esp; 1997 May; 197(5):341-5. PubMed ID: 9280968
    [Abstract] [Full Text] [Related]

  • 6. Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.
    Vela-Ojeda J, García-Ruiz Esparza MA, Rosas-Cabral A, Padilla-González Y, García-Chávez J, Tripp-Villanueva F, Sánchez-Cortés E, Ayala-Sánchez M, García-León LD, Montiel-Cervantes L, Rubio-Borja ME.
    Ann Hematol; 2002 Jul; 81(7):362-7. PubMed ID: 12185504
    [Abstract] [Full Text] [Related]

  • 7. A retrospective analysis of thirty-one cases of plasma cell leukemia from a single center in China.
    Peijing Q, Yan X, Yafei W, Dehui Z, Zengjun L, Junyuan Q, Yaozhong Z, Lugui Q.
    Acta Haematol; 2009 Jul; 121(1):47-51. PubMed ID: 19339770
    [Abstract] [Full Text] [Related]

  • 8. Plasma cell leukemia. A report on 11 patients and review of the literature.
    Pasqualetti P, Festuccia V, Collacciani A, Acitelli P, Casale R.
    Panminerva Med; 1996 Sep; 38(3):179-84. PubMed ID: 9009684
    [Abstract] [Full Text] [Related]

  • 9. Primary systemic amyloidosis with delayed progression to multiple myeloma.
    Rajkumar SV, Gertz MA, Kyle RA.
    Cancer; 1998 Apr 15; 82(8):1501-5. PubMed ID: 9554527
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combination chemotherapy for multiple myeloma with melphalan, prednisone, cyclophosphamide, vincristine, and carmustine (BCNU) (M-2 protocol).
    Tirelli U, Crivellari D, Carbone A, Veronesi A, Galligioni E, Trovò MG, Tumolo S, Grigoletto E.
    Cancer Treat Rep; 1982 Nov 15; 66(11):1971-3. PubMed ID: 6897205
    [Abstract] [Full Text] [Related]

  • 14. Plasma cell leukemia: a rare condition.
    Jiménez-Zepeda VH, Domínguez VJ.
    Ann Hematol; 2006 Apr 15; 85(4):263-7. PubMed ID: 16416115
    [Abstract] [Full Text] [Related]

  • 15. Plasma cell leukemia: response to conventional myeloma therapy.
    Gailani S, Seon BK, Henderson ES.
    J Med; 1977 Apr 15; 8(6):403-14. PubMed ID: 272434
    [Abstract] [Full Text] [Related]

  • 16. [Primary plasma cell leukemia--a comprehensive analysis of 44 cases].
    Cai ZJ.
    Zhonghua Zhong Liu Za Zhi; 1990 Jul 15; 12(4):314-7. PubMed ID: 2272272
    [Abstract] [Full Text] [Related]

  • 17. Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single center experience).
    Kraj M, Pogłód R, Maj S, Pawlikowski J, Sokołowska U, Szczepanik J.
    Acta Pol Pharm; 2002 Jul 15; 59(6):478-82. PubMed ID: 12669777
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
    Akpek G, Koh HK, Bogen S, O'Hara C, Foss FM.
    Cancer; 1999 Oct 01; 86(7):1368-76. PubMed ID: 10506727
    [Abstract] [Full Text] [Related]

  • 19. [Non-secretory primary plasma cell leukemia with hyperammonemia].
    Kawano F, Tsukamoto A, Satoh M, Sanada I, Shido T, Miura K, Murakami T, Kaneko H, Takeya M, Matsuzaki H.
    Rinsho Ketsueki; 1991 Apr 01; 32(4):399-403. PubMed ID: 2067085
    [Abstract] [Full Text] [Related]

  • 20. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D, Bosković D, Radosević N, Elezović I, Tomin D, Gotić M, Antunović P.
    Srp Arh Celok Lek; 1996 Apr 01; 124(11-12):292-6. PubMed ID: 9132962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.